Senior insider sale
Chief Commercial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$1.54M
13.54K shares
What this filing means
KHAYAL TAMER I plans to sell 13.54K shares of TRANSMEDICS GROUP, INC. valued at approximately $1.54M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/1/2024ACC: 0001968582-24-000954
Officer· Chief Commercial Officer
Since May 2019
13.54K
Shares to sell
$1.54M
Approx. market value
7.63K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
11/1/2024
7.63KTotal acquired7.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2024 | Stock Option Exercise Cash | 7.63K | — |
| Total | 7.63K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.96K
Market value
$438.5K
10/1/2024
—Completed
Units to sell
2.96K
Market value
$472.4K
9/3/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
7.63K
Market value
$625.0K
11/1/2024
Total
Units
13.54K
Value
$1.54M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/1/2024 | 2.96K | $438.5K | — | Completed |
9/3/2024 | 2.96K | $472.4K | — | Completed |
| Planned — Approximate Date | ||||
11/1/2024 | 7.63K | $625.0K | Nasdaq | Planned |
| Total | 13.54K | $1.54M | ||